Effects of the non-steroidal MRA finerenone with and without concomitant SGLT2 inhibitor use in heart failure
Vaduganathan M, Claggett BL, Kulac IJ, et al.
Circulation. Pub. online 28 Sept 2024.
Leggi
Estimated long-term benefits of finerenone in heart failure: a prespecified secondary analysis of the FINEARTS-HF randomized clinical trial
Vaduganathan M, Claggett BL, Desai AS, et al.
JAMA Cardiol. Pub. online 27 Sept 2024.
Leggi
An evaluation of how exercise position statement guidelines are being used in the real world in type 1 diabetes: Findings from the type 1 diabetes exercise initiative (T1DEXI)
Jacobs PG, Chase Marak M, Calhoun P, et al.
Diabetes Res Clin Pract. Pub. online 27 Sept 2024.
Leggi
Effect of sodium-glucose co-transporter-2 inhibitors on survival free of organ support in patients hospitalised for COVID-19 (ACTIV-4a): a pragmatic, multicentre, open-label, randomised, controlled, platform trial
Kosiborod MN, Windsor SL, Vardeny O, et al.
Lancet Diabetes Endocrinol. 2024;12(10):725-734.
Leggi
Ertugliflozin to reduce arrhythmic burden in patients with ICDs/CRT-Ds
Benedikt M, Oulhaj A, Rohrer U, et al.
NEJM Evid. 2024;3(10):EVIDoa2400147.
Leggi
Effects of glucagon-like peptide-1 receptor agonists on glycated haemoglobin and continuous glucose monitoring metrics as adjunctive therapy to insulin in adults with type 1 diabetes: A meta-analysis of randomized controlled trials
Karakasis P, Koufakis T, Patoulias D, et al.
Diabetes Obes Metab. Pub. online 30 Sept 2024.
Leggi
Coronary artery disease risk prediction by combined stratification of low-density lipoprotein-cholesterol and high-density lipoprotein-cholesterol levels across different glucose statuses
Yachida J, Fujihara K, Harada Yamada M, et al.
Diabetes Obes Metab. Pub. online 24 Sept 2024.
Leggi
Ambulatory blood pressure monitoring and vascular complications in patients with type 1 diabetes mellitus – Systematic review and meta-analysis of observational studies
Costa Hoffmeister M, Hammel Lovison V, Priesnitz Friedrich E, da Costa Rodrigues T
Diabetes Res Clin Pract. Pub. online 27 Sept 2024.
Leggi
AIFA: Medicinale per uso umano, a base di insulina icodec, «Awiqli»: classificazione in apposita sezione (denominata classe C)
26/09/2024
Leggi
2024 ESC Guidelines for the management of elevated blood pressure and hypertension
McEvoy JW, McCarthy CP, Bruno RM, et al; ESC Scientific Document Group
Eur Heart J. Pub. online 30 Aug 2024.
Leggi